DAI (DLM-1/ZBP1) as a Genetic Adjuvant for DNA Vaccines That Promotes Effective Antitumor CTL Immunity

DNA vaccination is an attractive approach to induce antigen-specific cytotoxic CD8(+) T lymphocytes (CTLs), which can mediate protective antitumor immunity. The potency of DNA vaccines encoding weakly immunogenic tumor-associated antigens (TAAs) can be enhanced by codelivering gene-encoded adjuvants...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lladser, Alvaro, Mougiakakos, Dimitrios, Tufvesson, Helena, Ligtenberg, Maarten A, Quest, Andrew FG, Kiessling, Rolf, Ljungberg, Karl
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3048184/
https://ncbi.nlm.nih.gov/pubmed/21157438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.268
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares